AMAG Pharma Sells Off Women’s Health Product in Planned Divestment

AMAG Pharmaceuticals wants out of the women’s health business—and now it’s halfway there.

On Thursday the Waltham, MA-based biotech said it had found a buyer for prasterone (Intrarosa), a steroid designed to treat pain during intercourse associated with menopause, one of two commercialized drugs it has been shopping around.